People: AcelRx Pharmaceuticals Inc (ACRX.O)

ACRX.O on Consolidated Issue listed on NASDAQ Global Market

6.66USD
28 Nov 2014
Price Change (% chg)

$-0.24 (-3.48%)
Prev Close
$6.90
Open
$6.90
Day's High
$6.94
Day's Low
$6.64
Volume
144,726
Avg. Vol
641,792
52-wk High
$13.64
52-wk Low
$5.22

Search Stocks

Edwards, Mark 

Brief Biography

Mr. Mark G. Edwards is an Independent Director of AcelRx Pharmaceuticals, Inc. Mr. Edwards is Managing Director of Bioscience Advisors Inc., a biopharmaceutical consulting firm he founded in 2011. From July 2008 until December 2010, he was Managing Director and a Principal of Deloitte Recap LLC, a wholly-owned subsidiary of Deloitte Touche Tohmatsu, an audit and financial consulting services firm. Mr. Edwards was previously the Managing Director and founder of Recombinant Capital, Inc. (Recap), a consulting and database firm based in Walnut Creek, California, from 1988 until the sale of Recap to Deloitte in 2008. Prior to founding Recap in 1988, Mr. Edwards was Manager of Business Development at Chiron Corporation, a biotechnology company. He received his B.A. and M.B.A. degrees from Stanford University.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Adrian Adams

--

Richard King

2,623,920

Timothy Morris

--

Pamela Palmer

2,015,870

Badri Dasu

914,083

Lawrence Hamel

508,560
As Of 30 Dec 2013
Search Stocks